Artal Group’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250,000	Closed	-$2.93M	–	74
2024 Q2	$2.93M	Hold	250,000	–	–	0.07%	68
2024 Q1	$5.27M	Buy	+250,000	New	+$5.27M	0.13%	60
2020 Q4	–	Sell	-222,300	Closed	-$6.12M	–	146
2020 Q3	$6.12M	Sell	222,300 -11,700	-5%	-$322K	0.15%	78
2020 Q2	$8.62M	Sell	234,000 -16,000	-6%	-$589K	0.24%	63
2020 Q1	$8.1M	Buy	250,000 +105,000	+72%	+$3.4M	0.34%	48
2019 Q4	$5.94M	Hold	145,000	–	–	0.23%	57
2019 Q3	$5.16M	Hold	145,000	–	–	0.21%	61
2019 Q2	$7.45M	Sell	145,000 -25,000	-15%	-$1.28M	0.3%	57
2019 Q1	$9.74M	Hold	170,000	–	–	0.4%	41
2018 Q4	$7.13M	Buy	170,000 +20,000	+13%	+$839K	0.26%	37
2018 Q3	$11.3M	Hold	150,000	–	–	0.29%	29
2018 Q2	$10.8M	Sell	150,000 -100,000	-40%	-$7.18M	0.23%	30
2018 Q1	$7.46M	Hold	250,000	–	–	0.09%	34
2017 Q4	$8.31M	Buy	250,000 +90,000	+56%	+$2.99M	0.13%	22
2017 Q3	$5.27M	Hold	160,000	–	–	0.09%	34
2017 Q2	$3.16M	Hold	160,000	–	–	0.06%	54
2017 Q1	$3.09M	Hold	160,000	–	–	0.07%	54
2016 Q4	$2.97M	Sell	160,000 -140,000	-47%	-$2.6M	0.07%	42
2016 Q3	$4.2M	Buy	300,000 +100,000	+50%	+$1.4M	0.08%	41
2016 Q2	$1.6M	Buy	200,000 +40,000	+25%	+$320K	0.03%	45
2016 Q1	$1.73M	Hold	160,000	–	–	0.03%	40
2015 Q4	$2.66M	Buy	160,000 +42,600	+36%	+$707K	0.05%	37
2015 Q3	$2.59M	Buy	+117,400	New	+$2.59M	0.06%	29